Well done me too and not a seller stand by for a new price target from Morgans currently $4.98.
I like the last bit on their research note of today:
"We continue to believe that IPH ticks most investment boxes with high EBITDA margins,solid earnings growth.high ROE,strong cash-flow conversion and great balance sheet which should allow further acquisitions over the coming months and years.................BUY maintained".
- Forums
- ASX - By Stock
- IPH
- Double UP Performance
Double UP Performance, page-3
Featured News
Add IPH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.08 |
Change
-0.060(1.17%) |
Mkt cap ! $1.578B |
Open | High | Low | Value | Volume |
$5.17 | $5.19 | $5.08 | $2.281M | 446.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 19240 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.10 | 2799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1335 | 5.980 |
6 | 25069 | 5.950 |
2 | 6370 | 5.940 |
1 | 3489 | 5.930 |
1 | 534 | 5.920 |
Price($) | Vol. | No. |
---|---|---|
5.990 | 2951 | 3 |
6.000 | 5688 | 3 |
6.010 | 8304 | 2 |
6.020 | 7870 | 3 |
6.030 | 16750 | 2 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
IPH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online